Division of Pulmonary, Allergy and Critical Care Medicine University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.
Division of Health Informatics and Implementation Science, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01655, USA.
J Cancer Educ. 2022 Aug;37(4):1161-1165. doi: 10.1007/s13187-020-01933-9. Epub 2021 Jan 7.
The Centers for Medicare and Medicaid Services has mandated in-person shared decision-making (SDM) counseling with the use of one or more decision aids (DAs) prior to lung cancer screening. We developed a single-page, paper-based, encounter DA (EDA) to be used within a clinician-patient encounter for lung cancer screening and conducted a pre-post pilot intervention study to evaluate its feasibility and effects on patient decisional conflict. Patients referred to a pulmonary practice-based lung cancer screening program were surveyed before and after an SDM visit with a pulmonologist, who used the EDA to counsel the patient. Patient knowledge of the mortality benefit from screening and the frequency of abnormal screening test results was evaluated after the visit, while decisional conflict was measured before and after the visit using the Decisional Conflict Scale (DCS). Twenty-three patients participated (mean age = 65.8 years; 43% female; mean smoking history = 57.8 pack-years; 48% currently smoking). Following the visit, 28% of participants correctly understood the mortality benefit of lung cancer screening, while 82% understood the frequency of abnormal screening tests. The mean total DCS score decreased from 35.0 to 0.2 after the visit (p < 0.001). These data suggest that a single-page, paper-based EDA is feasible and potentially effective in reducing decision conflict when used within a SDM visit, although more research is needed to establish the independent effects of the EDA, and future efforts to promote SDM may need to devote greater attention to improving patient understanding of the mortality benefit of screening.
医疗保险和医疗补助服务中心已要求在肺癌筛查前进行面对面的共享决策(SDM)咨询,并使用一种或多种决策辅助工具(DA)。我们开发了一种单页纸质的基于就诊的 DA(EDA),用于肺癌筛查就诊期间的医患交流,并进行了一项预-后试点干预研究,以评估其可行性及其对患者决策冲突的影响。被转诊到以肺科医生为基础的肺癌筛查项目的患者在与肺科医生进行 SDM 就诊前后接受了调查,该医生使用 EDA 对患者进行了咨询。在就诊后评估了患者对筛查死亡率获益的了解程度和异常筛查检测结果的频率,而在就诊前后使用决策冲突量表(DCS)测量了决策冲突。共有 23 名患者参与(平均年龄为 65.8 岁;43%为女性;平均吸烟史为 57.8 包年;48%目前吸烟)。就诊后,28%的参与者正确理解了肺癌筛查的死亡率获益,而 82%的参与者理解了异常筛查检测的频率。就诊后,DCS 的平均总分从 35.0 降至 0.2(p<0.001)。这些数据表明,在 SDM 就诊中使用单页纸质的 EDA 是可行的,并且有可能降低决策冲突,但需要更多的研究来确定 EDA 的独立效果,未来促进 SDM 的努力可能需要更多关注提高患者对筛查死亡率获益的理解。